Skip to main content
Toggle navigation
Search
Home
Presentation Icons
Surgery Day
Bench-to-Bedside
SIU@U
Session: Designing the Future: Trials in Motion
SYMP-27: Preliminary Results From Legend: a Phase 2 Study of Detalimogene Voraplasmid, a Novel, Investigational, Non-Viral Genetic Medicine for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
Saturday, November 1, 2025
12:15 - 12:30
GMT+0
Speaker(s)
Gautier Marcq
Assistant Professor
Lille University, France